Learn More
CD135 Mouse anti-Human, Brilliant Violet 510, Clone: 4G8, BD Optibuild™
Description
The 4G8 monoclonal antibody specifically binds to CD135 which is also known as FMS-like tyrosine kinase 3 (FLT3), Fetal liver kinase 2 (FLK2) and Stem cell tyrosine kinase 1 (STK1). CD135 is a 155-160 kDa type I transmembrane glycoprotein. It belongs to subclass III of the receptor tyrosine kinase (RTK) family which includes receptors for M-CSF (CD115), SCF/c-Kit Ligand (CD117), and PDGF (CD140a and CD140b). CD135 is expressed on multipotential, myelomonocytic and primitive B-cell progenitors. The most primitive hematopoietic progenitor cells express low levels of CD135. CD135 plays the role of growth factor receptor for early hematopoietic progenitors. Reports from studies with knockout mice have shown that targeted CD135 disruption impaired the development of primitive progenitor cells of all hematopoietic lineages with significant impact on lymphopoietic precursors.
Specifications
Specifications
| Antigen | CD135 |
| Classification | Monoclonal |
| Clone | 4G8 |
| Concentration | 0.2mg/mL |
| Conjugate | Brilliant Violet 510 |
| Formulation | Aqueous buffered solution containing ≤0.09% sodium azide. |
| Gene Alias | FLK2, FLT-3, Fms-related tyrosine kinase 3, STK-1 |
| Host Species | Mouse |
| Immunogen | Human FLT3 Transfected Cell Line |
| Purification Method | Affinity Purified |
| Show More |
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.